Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.52 (
PNGase F
)
1,527
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Changes in serum glycans discriminate between disease statuses in cancer. A similar connection has not been established in the context of infectious diseases such as tuberculosis (TB). The inflammation arising from infection by
Mycobacterium tuberculosis
may affect host protein glycosylation, thereby providing information about disease status in TB. A mouse model of infection was used to study glycoprotein N-glycosylation in serum. Following digestion of serum glycoproteins with peptide-
N
-glycosidase F (
PNGase F
), released glycans were permethylated and analyzed by multidimensional mass spectrometry (MS). Conditions included naive or
Mycobacterium bovis
BCG
-vaccinated animals, which were either uninfected or infected with
M. tuberculosis
MS results were validated by lectin blotting. We found that both glycoprotein fucosylation and sialylation were particularly sensitive to
M. tuberculosis
infection. We observed that
M. tuberculosis
infection elevates serum IgM levels and induces changes in glycosylation that could inform about the disease.
IMPORTANCE
We demonstrate that
M. tuberculosis
infection influenced host protein glycosylation in a mouse model. The mechanism by which infection modifies glycans in serum proteins is not understood. Investigation of the regulation of such modifications by
M. tuberculosis
opens a new field that could lead to the discovery of novel biomarkers. Validation of such findings in human samples will reveal the clinical relevance of these findings.
...
PMID:Serum IgM Glycosylation Associated with Tuberculosis Infection in Mice. 3091 63